Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Leukemic Stem Cells: A ReviewO'Brien, J. A. ; Rizzieri, D. A.Cancer investigation, 2013-05, Vol.31 (4), p.215-220 [Periódico revisado por pares]New York, NY: Informa HealthcareTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Severe Pulmonary Toxicity After Myeloablative Conditioning Using Total Body Irradiation: An Assessment of Risk FactorsKelsey, Chris R., M.D ; Horwitz, Mitchell E., M.D ; Chino, Junzo P., M.D ; Craciunescu, Oana, Ph.D ; Steffey, Beverly, M.S ; Folz, Rodney J., M.D. Ph.D ; Chao, Nelson J., M.D ; Rizzieri, David A., M.D ; Marks, Lawrence B., M.DInternational journal of radiation oncology, biology, physics, 2011-11, Vol.81 (3), p.812-818 [Periódico revisado por pares]New York, NY: Elsevier IncTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Haploidentical Transplantation for LeukemiaKanda, Junya ; Chao, Nelson J. ; Rizzieri, David A.Current oncology reports, 2010-09, Vol.12 (5), p.292-301 [Periódico revisado por pares]New York: Current Science IncTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
A phase I study with CP-4055 in patients with hematologic malignanciesO'Brien, S. M. ; Vey, N. ; Rizzieri, D. A. ; Kantarjian, H. M. ; Prebet, T. ; Ravandi, F. ; Jacobsen, T. F. ; Nilsson, B. I. ; Staudacher, K. ; Giles, F. J.Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.2532-2532 [Periódico revisado por pares]Texto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Anti proliferative activity of ELACYTac (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cellsAdams, David J ; Sandvold, Marit L ; Myhren, Finn ; Jacobsen, Tove F ; Giles, Frank ; Rizzieri, David ALeukemia & lymphoma, 2008-04, Vol.49 (4), p.786-797 [Periódico revisado por pares]Texto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cellsAdams, David J ; Sandvold, Marit L ; Myhren, Finn ; Jacobsen, Tove F ; Giles, Frank ; Rizzieri, David ALeukemia & lymphoma, 2008-04, Vol.49 (4), p.786 [Periódico revisado por pares]United StatesTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemiaO'Brien, Susan ; Rizzieri, David A. ; Vey, Norbert ; Ravandi, Farhad ; Krug, Utz O. ; Sekeres, Mikkael A. ; Dennis, Mike ; Venditti, Adriano ; Berry, Donald A. ; Jacobsen, Tove Flem ; Staudacher, Karin ; Bergeland, Trygve ; Giles, Francis J.British journal of haematology, 2012-09, Vol.158 (5), p.581-588 [Periódico revisado por pares]Oxford: Blackwell Publishing LtdTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Amonafide + ara-C in secondary acute myeloid leukemia (sAML): Consistent efficacy in poor risk populationsRizzieri, D. A. ; Erba, H. P. ; O'Donnell, M. ; Powell, B. L. ; Lundberg, A. S. ; Bennett, J. M. ; Capizzi, R. L.Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.7027-7027 [Periódico revisado por pares]Texto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemiaO'Brien, Susan ; Rizzieri, David A ; Vey, Norbert ; Ravandi, Farhad ; Krug, Utz O ; Sekeres, Mikkael A ; Dennis, Mike ; Venditti, Adriano ; Berry, Donald A ; Jacobsen, Tove Flem ; Staudacher, Karin ; Bergeland, Trygve ; Giles, Francis JBritish Journal of Haematology, 2012-06 [Periódico revisado por pares]Wiley-BlackwellTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemiaRizzieri, David A. ; O'Brien, Jenny A. ; Broadwater, Gloria ; Decastro, Carlos M. ; Dev, Prakash ; Diehl, Louis ; Beaven, Anne ; Lagoo, Anand ; Gockerman, Jon P. ; Chao, Nelson J. ; Moore, Joseph O.Cancer, 2009-07, Vol.115 (13), p.2922-2929 [Periódico revisado por pares]Hoboken: Wiley Subscription Services, Inc., A Wiley CompanyTexto completo disponível |